Pharma BD Deal Intelligence
A durable but shrunken bet: P&G's $57B purchase gave it Gillette's razor franchise plus Oral-B and Braun, but a decade-plus of Dollar Shave Club and Harry's disruption cut US razor share from ~70-75% to ~50-54%, forcing an $8.0B goodwill write-down in 2019.
Gillette became a durable but shrunken P&G segment — strategically retained, financially a write-down-riddled disappointment relative to the $57B price.
Full analysis, sources & comparables →Ranks computed across 828 graded deals (Critic + Outcome Score both present).
P&G to acquire Gillette in $57B all-stock transaction at 0.975 P&G shares per Gillette share, an 18% premium; deal expected accretive by year 3 with…
P&G's October 2005 close of the Gillette acquisition created the world's largest consumer goods company, displacing Unilever to second place and bringing…
P&G recorded a $1.3 billion non-cash impairment on Gillette goodwill in January 2024, citing changes in grooming product use linked to hybrid/remote work;…
Source summaries from our enrichment pipeline; follow links for originals.
All 5 sources with sentiment breakdown →
P&G announces $57B acquisition of Gillette; includes Oral-B, Braun consumer health brands. Announced Jan 28, 2005.
Gillette became a durable but shrunken P&G segment — strategically retained, financially a write-down-riddled disappointment relative to the $57B price.
Assessment window: 15yr post-close.
This was a consumer products combination, not a therapeutic indication deal. Gillette brought five complementary CPG franchises into P&G: men's grooming/wet-shave (Gillette razors), oral care (Oral-B power and manual toothbrushes), small appliances (Braun electric shavers and household appliances), batteries (Duracell), and women's grooming (Venus). Strategic logic was billion-dollar brand portfolio consolidation, not pharmaceutical R&D.
Announced January 28, 2005 and closed October 1, 2005, the $57B all-stock acquisition was P&G's largest ever and created the world's largest consumer goods company, displacing Unilever to #2. Oral-B's combination with P&G's Crest dentifrice franchise created an integrated oral care platform competing with Colgate-Palmolive's Colgate brand and Church & Dwight's Arm & Hammer. Gillette razors retained dominant share against Schick (Energizer Holdings) and later Edgewell. Duracell competed against Energizer in alkaline batteries (Duracell was later sold to Berkshire Hathaway in 2016 for $4.7B). Warren Buffett, Gillette's largest shareholder via Berkshire Hathaway, called it a 'dream deal' and committed to buying additional P&G shares to bring Berkshire to 100M shares. P&G announced an $18-22B share repurchase to offset dilution, effectively making the deal ~60% stock / 40% cash equivalent. Long-term performance was mixed: P&G recorded a $1.3B Gillette goodwill impairment in January 2024 citing reduced shaving frequency in hybrid/remote work era (Motley Fool), though Gillette/Braun/Venus still drove two-thirds of P&G grooming category growth at that time.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Procter & Gamble / Gillette Company (this deal) | 2005 | $57.0B | 55 |
| Thermo Fisher Scientific Inc. / Life Technologies Corporation | 2013 | $15.1B | 84 |
| Merck KGaA / Sigma-Aldrich Corporation | 2014 | $17.0B | 80 |
| Becton, Dickinson and Company / C.R. Bard Inc. | 2017 | $24.0B | 77 |
| Johnson & Johnson / Synthes Inc. | 2011 | $19.7B | 77 |
| Thermo Fisher Scientific Inc. / PPD Inc. | 2021 | $17.4B | 77 |
| Danaher Corporation / GE Life Sciences Biopharma Business (now Cytiva) | 2019 | $21.4B | 76 |